Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
32.85
+0.09 (0.27%)
Feb 27, 2026, 3:00 PM CST
Market Cap5.03B -21.9%
Revenue (ttm)3.18B -20.1%
Net Income326.30M -23.8%
EPS2.16 -22.7%
Shares Out153.40M
PE Ratio15.19
Forward PEn/a
Dividend0.90 (2.71%)
Ex-Dividend DateApr 30, 2025
Volume1,127,300
Average Volume1,632,197
Open32.76
Previous Close32.76
Day's Range32.62 - 32.85
52-Week Range32.62 - 48.14
Beta0.44
RSI31.14
Earnings DateMar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It provides medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China. [Read more]

Sector Healthcare
Founded 1993
Employees 2,345
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2024, SHA:600976's revenue was 3.50 billion, a decrease of -16.81% compared to the previous year's 4.21 billion. Earnings were 362.18 million, a decrease of -30.54%.

Financial Statements